MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
BioXcel Therapeutics Current Ratio 2011-2026 | BTAI
Annual Current Ratio BioXcel Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.292 | 0.566 | 1.59 | 13.5 | 18.3 | 4.03 | 9.26 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.3 | 0.292 | 6.79 |
Quarterly Current Ratio BioXcel Therapeutics
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.33 | 0.19 | 0.29 | 0.36 | 0.47 | 0.57 | 0.71 | 1.04 | - | 1.59 | 2.08 | 2.96 | 12.4 | 13.5 | 16.6 | 20.5 | 14.7 | 16.6 | 16.6 | 16.6 | 16.6 | 3.83 | 3.83 | 3.83 | 3.83 | 9.35 | 9.35 | 9.35 | 9.35 | 0.58 | 0.58 | 0.58 | 0.58 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20.5 | 0.19 | 6.55 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Adagene
ADAG
|
2.3 | $ 2.62 | 28.82 % | $ 147 M |  China |
 |
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K |  USA |
 |
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M |  Canada |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.51 | 7.34 % | $ 8.45 B |  Australia |
 |
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
6.71 | - | - | $ 1.01 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.87 | $ 25.92 | -0.86 % | $ 1.26 B | USA |
 |
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
0.69 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | USA |
 |
Athira Pharma
ATHA
|
4.22 | - | - | $ 269 M | USA |
 |
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | USA |
 |
AVROBIO
AVRO
|
15.9 | - | 1083.1 % | $ 745 M | USA |
 |
BioLineRx Ltd.
BLRX
|
1.53 | $ 3.1 | 4.49 % | $ 908 M |  Israel |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
BioNTech SE
BNTX
|
7.22 | $ 116.27 | -1.86 % | $ 27.2 B | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
0.918 | $ 235.41 | 2.95 % | $ 5 B |  Danmark |
 |
Burford Capital Limited
BUR
|
2.14 | $ 9.74 | -1.37 % | $ 1.55 B | Britain |
 |
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | USA |
 |
Aytu BioScience
AYTU
|
1.47 | $ 2.66 | -1.85 % | $ 16.7 M | USA |
 |
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
2.73 | $ 67.49 | -3.02 % | $ 9.03 B | USA |
 |
Brickell Biotech
BBI
|
5.28 | - | -5.38 % | $ 6.06 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 4.51 | 8.41 % | $ 9.81 B | Israel |
 |
BeiGene, Ltd.
BGNE
|
2.29 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M | Israel |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.16 | - | -15.15 % | $ 60.3 M | Britain |
 |
AIkido Pharma
AIKI
|
6.48 | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | USA |
 |
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
6.32 | - | -9.72 % | $ 5.89 M | USA |
 |
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | USA |
 |
Coherus BioSciences
CHRS
|
0.765 | $ 2.04 | 28.3 % | $ 192 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |
 |
Biogen
BIIB
|
2.47 | $ 171.89 | -1.1 % | $ 25 B | USA |
 |
Bio-Path Holdings
BPTH
|
1.16 | - | - | $ 100 K | USA |
 |
BioVie
BIVI
|
8.46 | $ 1.2 | -3.7 % | $ 1.77 M | USA |
 |
Baudax Bio
BXRX
|
0.293 | - | 0.59 % | $ 63 K | USA |
 |
Calithera Biosciences
CALA
|
4.13 | - | -10.95 % | $ 876 K | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
5.22 | $ 44.32 | 7.3 % | $ 4.58 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | USA |